Report of Foreign Issuer (6-k)
May 07 2020 - 8:21AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF
FOREIGN PRIVATE ISSUER
PURSUANT TO
RULE 13a-16 OR 15d-16
UNDER THE
SECURITIES EXCHANGE ACT OF 1934
For the month of May 2020
Commission File Number 001-38810
STEALTH BIOTHERAPEUTICS CORP
(Translation of registrants name into English)
Stealth
BioTherapeutics Corp
c/o Intertrust Corporate Services (Cayman) Limited
190 Elgin Avenue, George Town
Grand Cayman
KY1-9005 Cayman Islands
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
FORM
20-F ☒ FORM 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
On May 7, 2020, Stealth BioTherapeutics Corp (the Company) issued a press release
announcing its unaudited financial results for the three months ended March 31, 2020 and operational progress. The press release issued by the Company in connection therewith is attached hereto as Exhibit 99.1 The information in this Form 6-K (including Exhibit 99.1) shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), nor shall be deemed
incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
EXHIBIT INDEX
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.
|
|
|
STEALTH BIOTHERAPEUTICS CORP
|
|
|
By:
|
|
/s/ Irene P. McCarthy
|
|
|
Irene P. McCarthy
|
|
|
Chief Executive Officer
|
|
Date: May 7, 2020
|
3
Stealth BioTherapeutics (NASDAQ:MITO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Stealth BioTherapeutics (NASDAQ:MITO)
Historical Stock Chart
From Sep 2023 to Sep 2024